Oxford BioDynamics Plc (LON:OBD – Get Free Report) was down 11.6% during trading on Wednesday . The company traded as low as GBX 0.94 ($0.01) and last traded at GBX 0.97 ($0.01). Approximately 4,693,215 shares were traded during trading, an increase of 14% from the average daily volume of 4,110,961 shares. The stock had previously closed at GBX 1.10 ($0.01).
Oxford BioDynamics Stock Down 12.4 %
The firm’s 50 day moving average is GBX 1.26 and its 200-day moving average is GBX 3.99. The firm has a market cap of £3.01 million, a PE ratio of -16.07 and a beta of 0.42. The company has a quick ratio of 2.80, a current ratio of 0.68 and a debt-to-equity ratio of 370.22.
Insider Activity
In other news, insider David Holbrook purchased 49,653 shares of the company’s stock in a transaction on Monday, October 28th. The stock was bought at an average cost of GBX 1 ($0.01) per share, for a total transaction of £496.53 ($619.42). Company insiders own 16.78% of the company’s stock.
Oxford BioDynamics Company Profile
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
Recommended Stories
- Five stocks we like better than Oxford BioDynamics
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- ESG Stocks, What Investors Should Know
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Manufacturing Stocks Investing
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
